Filter Results :

Your search for inhibitors returned 508 reports

Sort by


Crude Oil Flow Improvers (COFI) Market by Type (Paraffin Inhibitors, Asphaltene Inhibitors, Scale Inhibitors, Drag Reducing Agents, and Hydrate Inhibitors), Application (Extraction, Pipeline, and Refinery), Supply Mode - Global Forecast to 2021

22 Sep 2016  |  Published by:  MarketsandMarkets
Rise in crude oil production worldwide drives the COFI marketThe global market size of COFI is estimated to reach USD 1.73 billion by 2021 from 1.32 billion in 2016, at a CAGR of 5.5%. Excessive supply of oil worldwide, has pushed down oil prices. Countries such as the U.S. have made considerable in...

$ 5,650.00

Read More

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021

15 Sep 2016  |  Published by:  MarketsandMarkets
The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries...

$ 5,650.00

Read More

Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight

25 Aug 2016  |  Published by:  KuicK Research
Cancer is ever fastest growing global epidemic and one of the leading causes of death in the developed countries. It was observed that year 2015 alone witnessed more than 10 million new cancer cases. The number of new cancer cases is predicted to rise to 22 million within the next two decades....

$ 2,400.00

Read More

United States Dye Transfer Inhibitors Market Report 2021

16 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Dye Transfer Inhibitors in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering BASF SE Clariant International AG Novozymes A/S Other prominent vendors Air Products and Chemicals Akzo Nobe...

$ 3,800.00

Read More

Global Plasma-derived Immune Inhibitors Sales Market Report 2021

16 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Plasma-derived Immune Inhibitors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these reg...

$ 4,000.00

Read More

United States Alpha-glucosidase Inhibitors Sales Market Report 2021

15 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Alpha-glucosidase Inhibitors in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering Sanofi Bayer Takeda Pharmaceuticals Eli Lilly Merck & Co. Novo Nordisk Bristol-Myers Squibb Pfizer ...

$ 3,800.00

Read More

Global Kinase Inhibitors Market Report 2016

14 Aug 2016  |  Published by:  9Dimen Research
2016 Global Kinase Inhibitors Report is a professional and in-depth research report on the world's major regional market conditions of the Kinase Inhibitors industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).The re...

$ 2,850.00

Read More

Global Dye Transfer Inhibitors Market Research Report 2021

10 Aug 2016  |  Published by:  QYResearch
This report studies Dye Transfer Inhibitors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering BASF SE Clariant Intern...

$ 2,900.00

Read More

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Hematology, Rheumatology, Immunology), End User (Hospitals, Clinical Research Laboratories) - Global Forecast to 2021

04 Aug 2016  |  Published by:  MarketsandMarkets
The global plasma fractionation market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 26.07 billion by 2021 from USD 18.84 billion in 2016. Growth in this market is mainly attributed to growing aging population, rising incidences of bleeding and immune disorders, and gr...

$ 5,650.00

Read More

Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Insulin Like Growth Factor (IGF) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor (IGF) Inhibitors. The DelveInsights Report covers the product profiles in various ...

$ 1,250.00

Read More

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Insulin Like Growth Factor 2 (IGF-2) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor 2 (IGF-2) Inhibitors. The DelveInsights Report covers the product profiles in ...

$ 1,250.00

Read More

Integrase Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Integrase Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Integrase Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre...

$ 1,250.00

Read More

Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors. The DelveInsights Report covers ...

$ 1,250.00

Read More

Interleukin (IL) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin (IL) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including ...

$ 1,250.00

Read More

Interleukin-1 (IL-1) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-1 (IL-1) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-1 (IL-1) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development in...

$ 1,250.00

Read More
Total 508 records.